Stemtech (STEK) Consolidated Net Income (2012 - 2025)
Stemtech's (STEK) quarterly Consolidated Net Income came in at -$1.5 million in Q4 2025, down 273.77% year-on-year from $853025.1 in Q4 2024, and down 82.43% quarter-over-quarter from -$812541.0 in Q3 2025.
Stemtech (STEK) Consolidated Net Income (2012 - 2025) Analysis & Trends
Stemtech has disclosed Consolidated Net Income across 14 years of filings, most recently posting -$1.5 million for Q4 2025.
- Consolidated Net Income for Q4 2025 came in at -$1.5 million, down 273.77% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.0 million (down 7.35% YoY), and the FY2025 annual result was -$4.0 million, down 7.35% from the prior year.
- Consolidated Net Income came in at -$1.5 million for Q4 2025 at Stemtech, down from -$812541.0 in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $17.4 million in Q3 2022 to a low of -$25.0 million in Q2 2022.
- The 5-year median for Consolidated Net Income is -$830348.0 (2021), against an average of -$1.4 million.
- Peak annual rise in Consolidated Net Income reached 426.83% in 2022, while the deepest fall reached 3129.07% in 2022.
- Stemtech's Consolidated Net Income stood at -$848155.0 in 2021, then jumped by 36.13% to -$541732.0 in 2022, then tumbled by 244.08% to -$1.9 million in 2023, then soared by 78.72% to -$396580.0 in 2024, then plunged by 273.77% to -$1.5 million in 2025.
- The last three Consolidated Net Income figures came in at -$1.5 million (Q4 2025), -$812541.0 (Q3 2025), and -$296280.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Stemtech | - | - | 354,677.00 | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.48 Mn |
| Sep 30, 2025 | -812,541.00 |
| Jun 30, 2025 | -296,280.00 |
| Mar 31, 2025 | -1.46 Mn |
| Dec 31, 2024 | -396,580.00 |
| Sep 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -784,087.00 |
| Mar 31, 2024 | -1.42 Mn |
| Dec 31, 2023 | -1.86 Mn |
| Sep 30, 2023 | -1.04 Mn |
| Jun 30, 2023 | -290,916.00 |
| Mar 31, 2023 | -2.24 Mn |
| Dec 31, 2022 | -541,732.00 |
| Sep 30, 2022 | 17.39 Mn |
| Jun 30, 2022 | -24.97 Mn |
| Mar 31, 2022 | -509,402.00 |
| Dec 31, 2021 | -848,155.00 |
| Sep 30, 2021 | -5.32 Mn |
| Jun 30, 2021 | -773,223.00 |
| Mar 31, 2021 | -170,835.00 |